Epidemiology of Heart Failure in a Universal Healthcare system
Epidemiology of Heart Failure in a Universal Healthcare system
批准号:
10699755
负责人:
Veronique Roger
金额:
$12.27万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAgeAnxietyBlack raceBlood CirculationCaringCause of DeathCharacteristicsClinicalCodeCommunitiesCross-Sectional StudiesEnvironmentEpidemicEpidemiologyEthnic OriginEventHealth Services AccessibilityHealthcareHealthcare SystemsHeart failureHigh PrevalenceHypertensionICD-10-CMIndividualInternational Classification of DiseasesMeasuresMilitary PersonnelModelingModificationMorbidity - disease rateOdds RatioPersonsPopulationPost-Traumatic Stress DisordersPrevalencePreventionProxyPublishingRaceResearchRisk FactorsSmokingVeteransWomanagedaging populationbeneficiaryexperiencehealth care availabilityhealth disparityinsightlow socioeconomic statusmalemenmiddle agemilitary health systemmilitary servicemortalitypre-clinicalsexsex disparitysociodemographicstrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We conducted a cross-sectional study of MHS beneficiaries aged 18 to 64 years to measure the prevalence of HF stages in 2018-19 and evaluate disparities by sex, race, and other sociodemographic characteristics. We defined HF stages defined as preclinical HF (Stage A or B) or clinical HF (stages C/D). Clinical HF was defined by International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes.
Among 6,375,086 MHS beneficiaries aged 18 to 64 years, the prevalence of both preclinical and clinical HF was remarkably high (18% and 2.5%). Persons with preclinical HF were mainly middle aged with similar proportions of men and women. Persons with HF were slightly older, mainly men, retired from military service, of enlisted rank (proxy for lower socio-economic status). Male sex, older age, black race, and lower rank were univariately associated with higher relative odds of both preclinical and clinical HF. After multivariable adjustment, male sex, black race and lower rank were independently associated with large increases in prevalent HF.
All stages of HF are highly prevalent among MHS beneficiaries of working age. The high prevalence of preclinical HF particularly noticeable among Black beneficiaries delineates critical avenues for prevention. The large excess odds of HF among Black beneficiaries and among individuals with lower socio-economic status underscore the urgent need for further research to understand and address the determinants of these disparities.
Published abstract Roger VL, Banaag A, Korona-Bailey J, Turner C, Haigney MC, Koehlmoos TP. Heart Failure In A Universally Insured Working Age Population: The Military Community Experience. Circulation. 2022;145(Suppl_1).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Heart failure proteomics: an epidemiology study
-
批准号:10699754
-
项目类别:
-
资助金额:$166.48万
-
财政年份:--
-
负责人:Veronique Roger
-
依托单位:
Rurality and Heart Failure: The Southern Community Cohort Study
-
批准号:10929210
-
项目类别:
-
资助金额:$27.86万
-
财政年份:--
-
负责人:Veronique Roger
-
依托单位:
Heart failure proteomics: an epidemiology study
-
批准号:10929212
-
项目类别:
-
资助金额:$195.01万
-
财政年份:--
-
负责人:Veronique Roger
-
依托单位:
Heart failure Metabolomics: NMR studies
-
批准号:10699753
-
项目类别:
-
资助金额:$36.8万
-
财政年份:--
-
负责人:Veronique Roger
-
依托单位:
Epidemiology of Heart Failure in a Universal Healthcare system
-
批准号:10929213
-
项目类别:
-
资助金额:$13.93万
-
财政年份:--
-
负责人:Veronique Roger
-
依托单位:
Rurality and Heart Failure: The Southern Community Cohort Study
-
批准号:10699752
-
项目类别:
-
资助金额:$24.53万
-
财政年份:--
-
负责人:Veronique Roger
-
依托单位:
Heart failure Metabolomics: NMR studies
-
批准号:10929211
-
项目类别:
-
资助金额:$41.79万
-
财政年份:--
-
负责人:Veronique Roger
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: